ClinicalTrials.gg
Sign In
RecruitingNCT06311630Updated Mar 15, 2024

Comparative Study of Analgesic Effect of Ultrasound Guided PENG Block vs FEMORAL BLOCK in Hip Fracture

An observational study in Hip Fracture, sponsored by Jubilee Mission Medical College and Research Institute. Recruiting at 1 site in India. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-03-15.

Sponsored by Jubilee Mission Medical College and Research Institute · Observational

From the registry’s dates

  • Primary completion was expected by Jan 2025, 1 year 9 months ago, but the record still lists the study as recruiting.
  • Started May 2023; still recruiting 3 years 5 months later.
Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
70
Ages
18 Years and older
Sex
All
01

Study summary

To study the analgesic effect of ultrasound guided PENG Block vs Femoral nerve block in patients with Hip fracture presenting to Emergency department

Read the detailed description

comparative study of analgesic effect of ultrasound guided PENG block vs femoral nerve block in patients presenting to emergency department

02

Conditions studied

  • Hip Fracture

Browse trials for

03

In context

Hip Fractures

842 studies on the registry are indexed under Hip Fractures; 165 are open to participants now.

This study's planned enrollment of 70 is below the median of 149 across 280 observational studies indexed under Hip Fractures.

Browse Hip Fractures studies →

Lead sponsor

Jubilee Mission Medical College and Research Institute is the lead sponsor of 25 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

All patients with Hip fracture presenting to Emergency department

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults more than or equal to 18 yrs with Hip fracture
  • patients who consent for procedure

Exclusion criteria

Exclusion Criteria:

  • history of allergy to local anaesthetics
  • pregnant or lactating women
  • infection or burns at injection site
  • patients with polytrauma
  • patients with hemodynamic instability
  • patients with low GCS
  • patients on anticoagulant or hematological disorders
  • injuries with neurovascular compromise on affected limb
  • patients with distorted anatomy
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
70 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Comparative Study of Analgesic Effect of Ultrasound Guided PENG Block With FEMORAL NERVE BLOCK in Patients With Hip Fracture as assessed by NRS pain scoring scale by patient

    To study the analgesic effect of peng block vs Femoral nerve block in patients with Hip fracture by NRS (NUMERIC RATING SCALE FROM 0-10) WITH 0 MEANING NO PAIN AND 10 MEANING SEVERE PAIN

    Time frame: 1 hour

Secondary outcomes

  1. Time taken for each technique

    Time taken for thr each procedure

    Time frame: 1 hour

  2. Time taken for adequate analgesia

    To study time taken for analgesic effect after procedure

    Time frame: 1hour

  3. Incidence of complications

    To look for any immediate and late complications

    Time frame: 7 days

  4. To note if rescue analgesic is required

    To note if opioids are required as rescue analgesia

    Time frame: 1 hour

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2023 (actual). Primary completion is estimated for Jan 2025, 20 months after the start.

Of 107 non-industry observational studies under Hip Fractures, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 65. This study's planned 20 months is below that.

Counting every sponsor, half of 124 studies reached it within 28 months; a quarter within 12 and three quarters within 83.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 8, 2024
First posted
Mar 15, 2024
StartActual
May 20, 2023
Primary completionEst.
Jan 20, 2025
CompletionEst.
Mar 20, 2025
Last update
Mar 15, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 15, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06311630
Lead sponsor
Jubilee Mission Medical College and Research Institute
Responsible party
Dr. Jogi Varghese (Junior resident, Jubilee Mission Medical College and Research Institute) — Principal investigator
First posted
Mar 15, 2024
Start date
May 20, 2023
Primary completion
Jan 20, 2025 (estimated)
Completion
Mar 20, 2025 (estimated)
Last update
Mar 15, 2024

Study contacts

Jogi Varghese, MBBS
Contact
jogi1907@gmail.com
9947004222
Rajeev P.C, MBBS MD
Contact
984602236
Jogi Varghese, MBBS
principal investigator

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Hip Fractures →

Other studies from this sponsor

Jubilee Mission Medical College and Research Institute

Start the discussion